鈺緯

-1.15 (-3.53%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

31.4010成交張數19.15本益比1.90股價淨值比6.37%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	15	10	34.0%	2.41	16.49	9.8%	6.7%	0.7	0.7
2026Q1	14	9	32.3%	2.50	15.96	9.5%	6.7%	-0.2	-0.2
2025Q4	14	10	24.0%	3.35	17.54	8.7%	6.8%	0.1	0.1
2025Q3	13	10	24.0%	3.33	17.01	8.3%	6.5%	-0.4	-0.4
2025Q2	14	10	30.0%	2.71	16.79	8.9%	6.5%	0.5	0.5
2025Q1	13	10	27.7%	2.90	16.05	9.7%	7.2%	0.0	0.0
2024Q4	13	11	19.1%	4.18	17.57	9.0%	7.3%	0.4	0.4
2024Q3	13	10	17.5%	4.54	17.17	8.9%	7.4%	0.1	0.1
2024Q2	13	10	23.9%	3.36	16.96	9.5%	7.3%	0.2	0.2
2024Q1	13	10	23.8%	3.34	16.39	7.8%	6.0%	0.5	0.5
2023Q4	12	10	17.0%	4.70	17.19	7.2%	5.9%	0.8	0.8
2023Q3	12	10	17.3%	4.55	16.39	7.4%	6.2%	0.0	0.0
2023Q2	13	10	21.8%	3.59	16.07	7.9%	6.3%	1.5	1.5
2023Q1	12	10	20.9%	3.73	15.85	7.0%	5.8%	0.2	0.2
2022Q4	13	10	18.8%	4.16	16.45	5.0%	4.1%	1.1	1.1
2022Q3	12	10	15.4%	4.95	16.13	2.8%	2.3%	0.1	0.1
2022Q2	12	10	17.4%	4.35	15.74	2.1%	1.8%	0.4	0.4
2022Q1	12	10	15.5%	4.83	16.02	2.4%	2.0%	-1.0	-1.0
2021Q4	12	10	16.5%	4.55	15.97	2.2%	1.9%	0.1	0.0
2021Q3	12	10	16.5%	4.48	16.05	1.7%	1.4%	-0.4	-0.4
2021Q2	12	10	15.4%	4.77	16.04	0.2%	0.2%	0.1	0.0
2021Q1	11	10	13.1%	5.53	15.99	1.6%	1.4%	0.2	0.1
2020Q4	11	10	11.2%	6.45	16.01	1.6%	1.4%	0.6	0.5
2020Q3	13	10	21.9%	3.43	16.11	2.0%	1.7%	-0.7	-0.8
2020Q2	13	11	15.6%	4.87	14.98	2.9%	2.4%	-0.1	-0.1
2020Q1	13	11	14.3%	5.36	15.07	2.8%	2.4%	0.1	-0.0
2019Q4	13	11	12.9%	5.88	15.24	4.8%	4.3%	0.4	0.4
2019Q3	13	11	12.7%	6.02	15.26	5.2%	4.6%	0.2	0.1
2019Q2	14	11	20.3%	3.87	15.09	4.9%	4.1%	-0.0	-0.0
2019Q1	14	12	12.5%	6.23	16.24	5.1%	4.5%	-0.1	-0.1
2018Q4	13	12	10.5%	7.33	15.92	5.2%	4.4%	0.0	0.0
2018Q3	14	12	9.9%	7.78	16.69	-0.5%	-0.4%	0.2	0.2
2018Q2	14	12	10.9%	7.10	16.58	-18.2%	-14.2%	-0.2	-0.2
2018Q1	13	12	10.5%	7.29	16.23	-17.7%	-12.3%	0.8	0.7
2017Q4	11	8	24.0%	2.88	14.84	-30.2%	-21.3%	0.6	0.6
2017Q3	12	7	37.2%	1.95	14.96	-36.6%	-22.2%	0.2	0.2
2017Q2	14	9	33.1%	2.15	18.66	-14.8%	-8.9%	0.1	0.1
2017Q1	17	9	47.0%	1.62	18.15	-15.5%	-8.8%	-0.5	-0.6
2016Q4	15	10	33.6%	2.19	19.51	–	–	1.0	1.0
2016Q3	16	9	40.8%	1.62	20.82	–	–	-0.1	-0.1